Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Bibenzyl compound, preparation method thereof, and application thereof in preparation of antitumor medicines

A compound and tumor technology, applied in the fields of anti-tumor drugs, ether preparation, drug combination, etc., can solve the problems such as no bibenzyl compound anti-tumor drug research reports.

Inactive Publication Date: 2017-02-01
CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there is no research report that the bibenzyl compound of the present invention is used for the preparation of antitumor drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bibenzyl compound, preparation method thereof, and application thereof in preparation of antitumor medicines
  • Bibenzyl compound, preparation method thereof, and application thereof in preparation of antitumor medicines
  • Bibenzyl compound, preparation method thereof, and application thereof in preparation of antitumor medicines

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0115] Example 1, the extraction and structural identification of compound F

[0116] (1) Extraction of medicinal materials:

[0117] Dried white and medicinal material coarse powder (3kg), reflux extraction with 95% ethanol 3 times (30L×3), 2h each time;

[0118] (2) Separation and purification of components:

[0119] 1. Ethanol extract (90L) was concentrated and dried under reduced pressure to obtain 510g of semi-solid liquid extract;

[0120] ②. Disperse the semi-solid liquid extract (500g) with water (5L), extract with ethyl acetate and n-butanol (20L) successively, combine the ethyl acetate part, recover the solvent under reduced pressure, and obtain 160g of ethyl acetate extract;

[0121] 3. Adopt silica gel column chromatography to separate ethyl acetate extract (160g), petroleum ether: acetone carries out gradient elution, and the eluent is detected by thin-layer chromatography, and obtains the elution when petroleum ether: acetone=30:1 Liquid Fr.16;

[0122] The c...

Embodiment 2

[0136] Example 2, the extraction and structural identification of compound G

[0137] (1) Extraction of medicinal materials:

[0138] Dried white and medicinal material coarse powder (3kg), reflux extraction with 95% ethanol 3 times (30L×3), 2h each time;

[0139] (2) Separation and purification of components:

[0140] 1. Ethanol extract (90L) was concentrated and dried under reduced pressure to obtain 510g of semi-solid liquid extract;

[0141] ②. Disperse the semi-solid liquid extract (500g) with water (5L), extract with ethyl acetate and n-butanol (20L) successively, combine the ethyl acetate part, recover the solvent under reduced pressure, and obtain 160g of ethyl acetate extract;

[0142] 3. Adopt silica gel column chromatography to separate ethyl acetate extract (160g), petroleum ether: acetone carries out gradient elution, and the eluent is detected by thin-layer chromatography, and obtains the elution when petroleum ether: acetone=30:1 Liquid Fr.16;

[0143] The c...

Embodiment 3

[0156] Example 3, the extraction and structural identification of compound H

[0157] (1) Extraction of medicinal materials:

[0158] Dried white and medicinal material coarse powder (3kg), reflux extraction with 95% ethanol 3 times (30L×3), 2h each time;

[0159] (2) Separation and purification of components:

[0160]1. Ethanol extract (90L) was concentrated and dried under reduced pressure to obtain 510g of semi-solid liquid extract;

[0161] ②. Disperse the semi-solid liquid extract (500g) with water (5L), extract with ethyl acetate and n-butanol (20L) successively, combine the ethyl acetate part, recover the solvent under reduced pressure, and obtain 160g of ethyl acetate extract;

[0162] 3. Adopt silica gel column chromatography to separate ethyl acetate extract (160g), petroleum ether: acetone carries out gradient elution, and the eluent is detected by thin-layer chromatography, and obtains the elution when petroleum ether: acetone=30:1 Liquid Fr.16;

[0163] The co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of a compound represented as the formula (IV), or pharmaceutically acceptable salts, crystal forms and solvates thereof, in preparation of a medicine for treating and / or preventing tumors, wherein R1, R4 and R6 are respectively and independently selected from hydrogen or a methyl group; R2, R3, R5 and R7 are respectively and independently selected from hydrogen or a structure represented as follows. The invention provides a novel application of bibenzyl compounds, and in particular, an application in preparation of a medicine for treating and / or preventing tumors. The compound has excellent inhibiting effects on tumor cells, especially, on lung carcinoma cells, wherein IC50 of the compound reaches 2-6 [mu]g / ml. The invention also provides a preparation method of the bibenzyl compounds.

Description

technical field [0001] The invention relates to a bibenzyl compound, a preparation method thereof and an application in the preparation of antitumor drugs. Background technique [0002] The existing literature reports that the following bibenzyl compounds have the efficacy and use of inhibiting passive cutaneous anaphylaxis and inhibiting the release of β-hexosaminidase from RBL-2H3 cells (basophilic leukemia cells) (See: Matsuda H et al. Antiallergic Phenanthrenes and... Planta Med 2004; 70:847-855): [0003] [0004] At present, there is no research report on the use of the bibenzyl compounds of the present invention for the preparation of antitumor drugs. Contents of the invention [0005] The purpose of the present invention is to provide a new application of the bibenzyl compounds as shown below, specifically the application in the preparation of drugs for treating and / or preventing tumors. [0006] Use of the compound represented by formula IV or its pharmaceuti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/085A61K31/09A61P35/00C07C41/34C07C41/36C07C41/38C07C43/23
CPCA61K31/085A61K31/09A61K36/898C07C41/34C07C41/36C07C41/38C07C43/23
Inventor 彭成戴鸥熊亮仰莲郭力
Owner CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com